SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 1 filers reported holding SAVARA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,731 | – | 1,200 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 42 | -70.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 142 | -22.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 184 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 184 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 184 | -10.7% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 206 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 206 | -2.8% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 212 | -41.8% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 364 | +156.3% | 0.00% | – |
| Q1 2016 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,896,551 | $9,034,000 | 11.23% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $15,226,000 | 1.48% |
| NEA Management Company, LLC | 24,137,931 | $31,621,000 | 0.91% |
| VR Adviser, LLC | 1,905,265 | $2,496,000 | 0.40% |
| Sio Capital Management, LLC | 716,262 | $938,000 | 0.31% |
| Ikarian Capital, LLC | 1,622,552 | $2,126,000 | 0.28% |
| FARALLON CAPITAL MANAGEMENT LLC | 8,505,403 | $11,142,000 | 0.05% |
| Marquette Asset Management, LLC | 93,246 | $122,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,864,551 | $8,993,000 | 0.02% |
| AXA S.A. | 6,955,664 | $9,111,960 | 0.01% |